Diagnopein provides a CSF Toxoplasma IgG & IgM test to detect Toxoplasma gondii infection in the central nervous system. The test differentiates between recent and pa
Cerebrospinal fluid (CSF) Toxoplasma IgG and IgM tests are advanced diagnostic assays designed to detect Toxoplasma gondii infection affecting the brain or central nervous system (CNS). This parasite can cause severe neurological complications, especially in immune-compromised patients, newborns, and individuals with HIV/AIDS.
The CSF Toxoplasma test helps differentiate between a past infection (IgG positive) and a recent or active infection (IgM positive). It is often recommended when a patient presents with symptoms such as headache, seizures, blurred vision, confusion, or other neurological signs suggesting toxoplasmic encephalitis.
Testing for Toxoplasma antibodies in CSF is crucial because this parasite can remain dormant for years and reactivate under immune suppression. Detecting it early through IgG and IgM markers is key to preventing severe brain damage or life-threatening conditions.
Enables early detection of active or latent Toxoplasma infection.
Aids in diagnosing unexplained neurological symptoms or brain inflammation.
Plays a vital role in managing HIV-positive patients or those undergoing immunosuppressive therapy.
Prevents potential congenital complications in pregnant women with a suspected CNS infection.
Helps monitor treatment response in patients with confirmed toxoplasmosis.
Regular monitoring of antibody levels in CSF provides insights into disease progression and treatment effectiveness. Diagnopein’s precise testing ensures transparency and accuracy, supporting clinical decisions with confidence.
The CSF Toxoplasma IgG & IgM test is performed using the patient’s cerebrospinal fluid, typically collected through a lumbar puncture (spinal tap) under sterile conditions. The process is safe, quick, and supervised by medical professionals.
Sample Collection: A small amount of CSF is withdrawn from the lower back under aseptic conditions.
Laboratory Analysis: The CSF sample undergoes ELISA testing to detect specific Toxoplasma antibodies (IgG & IgM).
Interpretation:
Elevated IgM levels indicate active or recent infection.
High IgG with absent IgM suggests past exposure or chronic infection.
Turnaround Time: Results are typically available within 24–48 hours at Diagnopein.
Diagnopein ensures accuracy through quality-controlled laboratory equipment and expert lab technicians trained in neuro-serology testing.
Detects active and chronic Toxoplasma infection accurately.
Helps differentiate CNS toxoplasmosis from other brain infections.
Critical for immunocompromised patients, especially with HIV/AIDS.
Aids physicians in making timely treatment decisions.
Facilitates targeted therapy and patient follow-up.
At Diagnopein, our goal is to deliver high-precision results with cost-effective packages so patients can receive quick and trustworthy diagnostics without delay.
NABL-certified and ISO-compliant diagnostic standards.
Highly trained pathologists specializing in infectious disease testing.
Rapid sample processing with 24–48 hour result delivery.
Affordable pricing with easy online test booking.
Personalized consultation and digital report access.
The sensitivity and specificity of the test can vary. False negatives may occur, especially in the early stages of infection. Confirmatory tests like PCR may be necessary for accurate diagnosis.
Additional tests may include PCR for Toxoplasma DNA, complete blood count (CBC), and imaging studies like MRI or CT scans to assess neurological changes.
This test is crucial for diagnosing cerebral toxoplasmosis, especially in immunocompromised individuals, such as those with HIV/AIDS, and in pregnant women to prevent congenital transmission.
CSF is collected via a lumbar puncture (spinal tap), where a needle is inserted into the lower back to access the spinal canal and obtain a sample.
